Drawing for ADDIS

USPTO serial 99760749

ADDIS

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
QUILICI, BRENDAN A
Law office
TMO LAW OFFICE 123

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with ADDIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John J Davis III

John J Davis III KEARNEY, MCWILLIAMS & DAVIS, PLLC55 Waugh #150Houston, TX 77007United States

Goods and services

ClassDescriptionStatusFirst use
042Biochemical research and development; Biochemical research and development services; Research and development of medicines; Pharmaceutical research and development; Research and development of mRNA drugs; Research and development of vaccines and medicines; Research and development services relating to medicines; Research and development in the field of biotechnology; Research and development in the field of pharmaceuticals; Research and development services of new pharmaceutical products; Research and development services in the field of genomics; Research and development services in the field of biotechnology; Research and development of pharmaceutical preparations for treating malignant tumours; Research and development services in the field of medical preparations; Research and development services in the field of pharmaceutical preparations; Research and development of new products in the field of pharmaceuticals; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development in the field of human organoid-based disease modelsACTIVEJun 27, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Aug 27, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2026DOCKASSIGNED TO EXAMINER—
Jul 30, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 23, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 23, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 23, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 13, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 13, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance